Compared to opioid pain management, peptide therapy carries no dependency or addiction potential, no respiratory depression risk, no tolerance development, and no overdose risk
Morigny, P., Houssier, M., Mouisel, E
In preclinical and laboratory studies, BPC-157 is widely investigated across multiple biological systems, particularly in research examining gastrointestinal integrity, connective tissue models, inflammatory signalling modulation, and vascular pathway dynamics
It is specifically designed for the reconstitution of research peptides and other compounds, ensuring the stabilization of lyophilized proteins for up to 28 days post-puncture